Nature’s Sunshine Products (NASDAQ:NATR) Rating Lowered to Buy at StockNews.com

StockNews.com downgraded shares of Nature’s Sunshine Products (NASDAQ:NATR) from a strong-buy rating to a buy rating in a report published on Monday morning.

Separately, DA Davidson cut their price target on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a buy rating on the stock in a research report on Monday, August 12th.

Nature’s Sunshine Products Price Performance

Shares of NATR opened at $13.80 on Monday. The business has a 50-day moving average of $14.72 and a 200-day moving average of $16.63. The company has a market capitalization of $258.47 million, a price-to-earnings ratio of 16.24 and a beta of 0.87. Nature’s Sunshine Products has a 1 year low of $10.81 and a 1 year high of $21.72.

Nature’s Sunshine Products (NASDAQ:NATR) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.18). Nature’s Sunshine Products had a return on equity of 9.79% and a net margin of 3.50%. The firm had revenue of $110.55 million for the quarter.

Insiders Place Their Bets

In other news, EVP Bryant J. Yates sold 3,068 shares of Nature’s Sunshine Products stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $15.30, for a total value of $46,940.40. Following the completion of the sale, the executive vice president now owns 98,852 shares in the company, valued at approximately $1,512,435.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Nature’s Sunshine Products

Large investors have recently made changes to their positions in the company. Jump Financial LLC acquired a new position in shares of Nature’s Sunshine Products during the fourth quarter worth approximately $208,000. Hillsdale Investment Management Inc. raised its holdings in Nature’s Sunshine Products by 50.3% during the fourth quarter. Hillsdale Investment Management Inc. now owns 198,730 shares of the company’s stock worth $3,436,000 after buying an additional 66,500 shares during the last quarter. Trexquant Investment LP bought a new position in shares of Nature’s Sunshine Products in the fourth quarter valued at $217,000. Wasatch Advisors LP acquired a new position in shares of Nature’s Sunshine Products during the fourth quarter valued at about $7,430,000. Finally, BNP Paribas Financial Markets grew its holdings in shares of Nature’s Sunshine Products by 12.7% during the first quarter. BNP Paribas Financial Markets now owns 15,207 shares of the company’s stock valued at $316,000 after buying an additional 1,715 shares during the last quarter. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature’s Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.